Frontiers in Oncology | Molecular and Cellular Oncology

Original Research

Published on 13 Jan 2025

Serum stromal cell-derived factor 1α as a prognostic indicator in elderly patients with acute myeloid leukemia receiving CAG-based chemotherapy

in Molecular and Cellular Oncology

Zhenzhen Wang
Jing Yuan
Nan Zhou
Jianfeng Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1521179

626 views

Original Research

Published on 13 Jan 2025

The role of VANGL2 in glioma oncogenesis and progression: insights into expression profiles and prognostic relevance

in Molecular and Cellular Oncology

Mingyu Zhao
Shanshuang Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1527226

815 views

Clinical Trial

Published on 09 Jan 2025

Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targets

in Molecular and Cellular Oncology

Tomasz Sirek
Katarzyna Król-Jatręga
Przemysław Borawski
Nikola Zmarzły
Dariusz Boroń
Piotr Ossowski
Olga Nowotny-Czupryna
Kacper Boroń
Dominika Janiszewska-Bil
Elżbieta Mitka-Krysiak

Frontiers in Oncology

doi 10.3389/fonc.2024.1515387

1,020 views

Review

Published on 09 Jan 2025

Copper in the colorectal cancer microenvironment: pioneering a new era of cuproptosis-based therapy

in Molecular and Cellular Oncology

Qixuan Feng
Yue Sun
Zhe Yang
Zhiyu Wang
Zhangyi Chen
Fang Liu
Lingxiang Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1522919

1,116 views

Review

Published on 07 Jan 2025

REV7: a small but mighty regulator of genome maintenance and cancer development

in Molecular and Cellular Oncology

Lara R. Maggs
Mitch McVey

Frontiers in Oncology

doi 10.3389/fonc.2024.1516165

1,243 views

Original Research

Published on 06 Jan 2025

Downregulation of hnRNPA1 inhibits hepatocellular carcinoma cell progression by modulating alternative splicing of ZNF207 exon 9

in Molecular and Cellular Oncology

Qi Ouyang
Wenhui He
Yiping Guo
Lin Li
Ying Mao
Xiang Li
Shuanglin Xiang
Xiang Hu
Jun He

Frontiers in Oncology

doi 10.3389/fonc.2024.1517459

1,020 views

Original Research

Published on 23 Dec 2024

Detection of aberrant locomotor activity in a mouse model of lung cancer via home cage monitoring

in Molecular and Cellular Oncology

Michele Tomanelli
Federica Guffanti
Giulia Vargiu
Edoardo Micotti
Mara Rigamonti
Francesca Tumiatti
Elisa Caiola
Mirko Marabese
Massimo Broggini

Frontiers in Oncology

doi 10.3389/fonc.2024.1504938

1,024 views

Mini Review

Published on 19 Dec 2024

Tryptase and tumor angiogenesis

in Molecular and Cellular Oncology

Domenico Ribatti

Frontiers in Oncology

doi 10.3389/fonc.2024.1500482

788 views
1 citation

Original Research

Published on 17 Dec 2024

Prmt1-mediated histone H4R3me2a methylation regulates the proliferation, migration and invasion of laryngeal cancer cells by affecting the expression level of NCOA5

in Molecular and Cellular Oncology

Linlu Li
Jiao Cui
Xiaoyu Li
Yuting Zhu
Hongfei Wu
Lanzhu Zhou

Frontiers in Oncology

doi 10.3389/fonc.2024.1489164

687 views

Original Research

Published on 16 Dec 2024

Transcriptomic analysis of ROS1+ non-small cell lung cancer reveals an upregulation of nucleotide synthesis and cell adhesion pathways

in Molecular and Cellular Oncology

Marc Terrones
Ken Op de Beeck
Guy Van Camp
Geert Vandeweyer
Ligia Mateiu

Frontiers in Oncology

doi 10.3389/fonc.2024.1408697

2,180 views

Original Research

Published on 16 Dec 2024

RNA-seq profiling identified a three-lncRNA panel in serum as potential biomarker for muscle-invasive bladder cancer

in Molecular and Cellular Oncology

Xiumei Jiang
Ailin Qu
Shoucai Zhang
Shuchao Jin
Lishui Wang
Yi Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1451009

764 views

Original Research

Published on 13 Dec 2024

MAFG-DT promotes prostate cancer bone metastasis through activation of the Wnt/β-catenin pathway

in Molecular and Cellular Oncology

Chongwen Wang
Zheng Zhou
Yongjie Ye
Liqiang Zhou
Jialun Wang
Zhi Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1461546

1,126 views

Review

Published on 09 Dec 2024

Pharmacological inhibition of the MAP2K7 kinase in human disease

in Molecular and Cellular Oncology

H. Daniel Lacorazza

Frontiers in Oncology

doi 10.3389/fonc.2024.1486756

1,010 views

Original Research

Published on 09 Dec 2024

Early in vitro results indicate that de-O-acetylated sialic acids increase Selectin binding in cancers

in Molecular and Cellular Oncology

Kakali Das
Megan Schulte
Megan Gerhart
Hala Bayoumi
Delayna Paulson
Darci M. Fink
Colin Parrish
Rachel Willand-Charnley

Frontiers in Oncology

doi 10.3389/fonc.2024.1443303

1,051 views

Original Research

Published on 06 Dec 2024

Direct comparison of an ultrasensitive real-time PCR assay with droplet digital PCR for the detection of PIK3CA hotspot mutations in primary tumors, plasma cell-free DNA and paired CTC-derived gDNAs

in Molecular and Cellular Oncology

Stavroula Smilkou
Loukas Kaklamanis
Ioanna Balgouranidou
Helena Linardou
Alkistis Maria Papatheodoridi
Flora Zagouri
Evangelia Razis
Stylianos Kakolyris
Amanda Psyrri
Christos Papadimitriou

Frontiers in Oncology

doi 10.3389/fonc.2024.1435559

949 views

Original Research

Published on 04 Dec 2024

miR-198 targets TOPORS: implications for oral squamous cell carcinoma pathogenesis

in Molecular and Cellular Oncology

Pankhuri Kaushik
Radha Mishra
Champaka Gopal
Arun Kumar

Frontiers in Oncology

doi 10.3389/fonc.2024.1485802

933 views